Is Amlodipine + Candesartan registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 4 valid registrations of Amlodipine + Candesartan, including Clodipan 16 mg and 5 mg (16,5 mg,mg, Capsule, hard, SAR 64.65); Clodipan 8 mg and 5mg (8,5 mg,mg, Capsule, hard, SAR 58.80); UNISIA 8 MG/2.5 MG TABLET (8,2.5 mg,mg, Tablet, SAR 67.00); UNISIA 8 MG/5MG TABLET (8,5 mg,mg, Tablet, SAR 68.55).

Active substances

Amlodipine + Candesartan

SFDA 4

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
Clodipan 16 mg and 5 mg	16,5 mg,mg	Capsule, hard · Oral use	28 Blister	SAR 64.65	NCE · Prescription	Aspen Healthcare	Valid
Clodipan 8 mg and 5mg	8,5 mg,mg	Capsule, hard · Oral use	28 Blister	SAR 58.80	NCE · Prescription	Aspen Healthcare	Valid
UNISIA 8 MG/2.5 MG TABLET	8,2.5 mg,mg	Tablet · Oral use	30 Blister	SAR 67.00	NCE · Prescription	Jazeera Pharmaceutical Industries (JPI)	Valid
UNISIA 8 MG/5MG TABLET	8,5 mg,mg	Tablet · Oral use	30 Blister	SAR 68.55	NCE · Prescription	Jazeera Pharmaceutical Industries (JPI)	Valid

Indications — CHI Daman Drug Formulary

HYPERTENSION

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.